还原型谷胱甘肽预防化疗所致神经毒性的Meta分析
《现代肿瘤医学》[ISSN:1672-4992/CN:61-1415/R]
- 期数:
- 2019年24期
- 页码:
- 4462-4467
- 栏目:
- 论著（综合诊疗）
- 出版日期:
- 2019-11-08
文章信息/Info
- Title:
- Meta-analysis on the efficacy of glutathione in preventing peripheral neurotoxicity of chemotherapeutic drugs
- Author(s):
- Si Qian; Chen Nan; Liu Xiangduan
- Department of Clinical Pharmacy,Zhengzhou People's Hospital,Henan Zhengzhou 450000,China.
- Keywords:
- glutathione; chemotherapeutic drugs; neurotoxicity; prevent; Meta-analysis
- 分类号:
- R730.53
- DOI:
- 10.3969/j.issn.1672-4992.2019.24.034
- 文献标识码:
- A
- 摘要:
- 目的：运用Meta分析法评价还原型谷胱甘肽预防化疗所致神经毒性的疗效与安全性，为临床提供循证依据。方法:检索Cochrane library、Pubmed、Ovid、中国期刊全文数据库、万方资源数据库、维普数据库和中国生物医学文献数据库系统，对纳入的随机对照试验（RCT），根据改良的Jadad量表进行文献质量评价，并运用RevMan 5.3软件进行统计学分析。结果:共纳入19项RCTs，1 436例患者。Meta分析结果显示，还原型谷胱甘肽组总的神经毒性发生率、严重神经毒性发生率及累积神经毒性发生率均低于对照组。亚组分析显示，与高剂量还原型谷胱甘肽（3 g/m2）相比，低剂量的还原型谷胱甘肽（1.5 g/m2）即可显著降低总神经毒性及严重神经毒性发生率。结论:低剂量的还原型谷胱甘肽可以有效预防化疗药物所致外周神经毒性的发生，值得临床应用。
- Abstract:
- Objective:To evaluate the efficacy and safety of glutathione in preventing peripheral neurotoxicity of chemotherapeutic drugs by Meta-analysis,and to provide evidence-based reference for clinical practice.Methods:The Cochrane Library,Pubmed,Ovid,CNKI,WanFang,VIP and CBM were retrieved by computer,and the quality assessment of qualified random control trials (RCT) was evaluated according to Jadad scale and statistic analysis was carried out by RevMan 5.3 software.Results:A total of nineteen RCTs and 1 436 patients were included.Meta-analysis indicated that total incidence of peripheral neurotoxicity,incidence of severe neurotoxicity and cumulative neurotoxicity in GSH group were significantly lower than control group.Subgroup Meta-analysis indicated that compared with high dose of glutathione (3 g/m2),lower dose of glutathione (1.5 g/m2) could significantly reduce the incidence of total neurotoxicity and severe neurotoxicity.Conclusion:Lower dose of glutathione could effectively prevent peripheral neurotoxicity of chemotherapeutic drugs,and worthy to be popularized in clinical application.
参考文献/References
［1］Grisold W,Cavaletti G,Windebank AJ.Peripheral neuropathies from chemotherapeutics and targeted agengts:Diagnosis,treatment,and prevention［J］.Neuro Oncol,2012,14(s14):45-54.
［2］Smith EM,Pang H,Cirrincione C,et al.Effect of duloxetine on pain,function,and quality of life among patients with chemotherapy-induced painful peripheral neuropathy:A randomized clinical trial［J］.JAMA,2013,309(13):1359-1367.
［3］ Seretny M,Currie GL,Sena ES,et al.Incidence,prevalence,and predictors of chemotherapy-induced peripheral neuropathy:A systematic review and meta-analysis［J］.Pain,2014,155(12):2461-2470.
［4］ Cindy Tofthagen,Kevin E Kip,Denise Passmore,et al.Usability and acceptability of a web-based program for chemotherapy-induced peripheral neuropathy［J］.Comput Inform Nurs,2016,34(7):322-329.
［5］ Gamelin E，Gamelin L，Bossi L，et al.Clinical aspects and molecular basis of oxaliplatin neurotoxicity：Current management and development of preventive measures［J］.Semin Oncol，2002，29（5 Suppl 15）：21.
［6］ Jadad AR,Moore RA,Carroll D,et al.Accseeing the quality of reports of randomized clinical trials:is blinding necessary［J］.Control clin Trials,1996,17(1):1-12.
［7］JF Smyth,A Bowman,T Perren,et al.Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin:Results of a double-blind,randomised trial［J］.Annals of Oncology,1997,8(6):569-573.
［8］Paola Milla,Mario Airoldi,Günther Weber,et al.Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer:Effect on oxaliplatin pharmacokinetics,Pt-DNA adduct formation,and neurotoxicity［J］.Anti-Cancer Drugs,2009,20(5):396-402.
［9］Stefano Cascinu,Vincenzo Catalano,Luigi Cordella,et al.Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer:A randomized,double-bind,placebo-controlled trial［J］.Journal of Clinical Oncology,2002,20(16):3478-3483.
［10］ Alexis D Leal,Rui Qin,Pamela J Atherton,et al.The use of glutathione for prevention of paclitaxel/carboplatin induced peripheral neuropathy:A phase III randomized,double-blind placebo-controlled study［J］.Cancer,2014,120(12):1890-1897.
［11］ Stefano Cascinu,Luigi Cordella,Elena Del Ferro,et al.Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer:A randomized double-blind placebo-controlled trial［J］.J Clin Oncol,1995,13(1):26-32.
［12］GUAN BB,WANG HG,LUO XF.The effect of GSH on the prevention of neurotoxicity induced by chemotherapy in malignant in malignant lymphoma［J］.J Medical Forum,2015,36(12):122-124.［关贝贝，王慧歌，罗显锋.恶性淋巴瘤化疗所致神经毒性应用谷胱甘肽的预防效果研究［J］.医药论坛杂志，2015,36(12):122-124.］
［13］LIU SH,WEI P,ZHANG LZ,et al.Clinical study of the protective effect of reduced glutathione on oxaliplatin-induced chronic neurotoxicity［J］.China Prac Med,2011,6(2):5-6.［刘淑红，魏萍，张灵智，等.还原型谷胱甘肽预防奥沙利铂慢性神经毒性的临床研究［J］.中国实用医药，2011,6(2):5-6.］
［14］YUAN HH,BAI YX,SUN XW,et al.Clinical observation of the prevention against neurotoxicity related to Oxaliplatin with use of reduced glutathione［J］.J Clin Med Pract,2011,15(11):47-50.［苑珩珩，白玉贤，孙秀威，等.还原型谷胱甘肽预防奥沙利铂所致神经毒性的临床观察［J］.实用临床医药杂志，2011,15(11):47-50.］
［15］WANG YJ,ZHANG WX,CHEN YS.The study of the protective effect of glutathione on vindesine-induced peripheral neurotoxicity［J］.The Practical Journal of Cancer,2008,23(1):79-82.［王颖杰，张文霞，陈友山.谷胱甘肽对长春地辛周围神经毒性防治作用的初步研究［J］.实用癌症杂志，2008,23(1):79-82.］
［16］HUANG P,LU H,CHEN RX,et al.Efficacy of reduced glutathione in preventing and treating neurotoxicity of oxaliplatin［J］.Chin J Clin Oncol Rehabil,2007,14(2):151-153.［黄平，逯华，陈日新，等.谷胱甘肽防治奥沙利铂神经毒性的临床观察［J］.中国肿瘤临床与康复，2007,14(2):151-153.］
［17］LI YL.Efficacy of reduced glutathione in preventing Oxaliplatin-induced neurotoxicity［J］.Chin J Mod Drug Appl,2014,8(19):143-144.［李岩磊.谷胱甘肽预防奥沙利铂所致神经毒性的临床效果观察［J］.中国现代药物应用，2014,8(19):143-144.］
［18］MA YH.Efficacy of glutathione in preventing Oxaliplatin-induced neurotoxicity［J］.Journal of North Pharmacy,2017,14(9):26-27.［马玉红.谷胱甘肽预防奥沙利铂所致神经毒性的临床效果观察［J］.北方药学，2017,14(9):26-27.］
［19］CAI DK,MIU JD.Randomized controlled trial of glutathione infusions in prevention of oxaliplatin-releated neurotoxicity［J］.Modern Preventive Medicine,2012,39(2):482-483.［蔡典琨，缪继东.谷胱甘肽预防奥沙利铂相关神经毒性的随机对照研究［J］.现代预防医学，2012,39(2):482-483.］
［20］ZHANG H,LUO RC,CUI YZ,et al.Efficacy of reduced glutathione in preventing chronic neurotoxicity of oxaliplatin in sixteen cases［J］.Journal of New Medicine,2008,39(3):159-161.［张华，罗荣城，崔彦芝，等.还原型谷胱甘肽预防草酸铂慢性神经毒性16例疗效观察［J］.新医学，2008,39(3):159-161.］
［21］HAN XH,SUN LH,ZOU J,et al.Protective effect of reduced glutathione on peripheral neuropathy by thalidomide in multiple myeloma［J］.Clinical Focus,2014,29(4):410-413.［韩秀华，孙丽华，邹健，等.还原型谷胱甘肽对多发性骨髓瘤患者沙利度胺相关的周围神经病变的保护作用［J］.临床荟萃，2014,29(4):410-413.］
［22］PANG DM,DENG YM,LAN XS,et al.Efficacy of reduced glutathione in preventing and reducing neurotoxicity of oxaliplatin［J］.Chin J Cancer Prev Treat,2010,17(24):2057-2059.［庞丹梅，邓燕明，蓝晓珊，等.还原型谷胱甘肽用于预防和降低奥沙利铂周围神经毒性的研究［J］.中华肿瘤防治杂志，2010,17(24):2057-2059.］
［23］LI HJ,DONG L,LI Y.Observation on preventive effect of reduced glutathione on oxaliplatin-induced neurotoxicity［J］.Clinical Education of General Pratice,2007,5(5):387-388.［李海金，董良，李英.还原型谷胱甘肽预防奥沙利铂神经毒性疗效观察［J］.全科医学临床与教育，2007,5(5):387-388.］
［24］BAI W,LIU YX.Observation on the effect of reduced glutathione in preventing and treating neurotoxicity of oxaliplatin［J］.Cancer Research and Clinic,2008,20(8):123-124.［白威，刘月香.还原型谷胱甘肽对奥沙利铂神经毒性的防治效果观察［J］.肿瘤临床与研究，2008,20(8):123-124.］
［25］YU H,JI JA,MA CH.Efficacy of glutathione in prevention of neurotoxicity induced by oxaliplatin［J］.Modern Oncology,2013,21(6):1432-1433.［于红，嵇钧安，马长华.谷胱甘肽预防奥沙利铂神经毒性的疗效观察［J］.现代肿瘤医学，2013,21(6):1432-1433.］
［26］WANG YQ,YANG XJ,WEI XC.Analysis of factors affecting chemotherapy-induced peripheral neurotoxicity［J］.Tianjin Phamacy,2017,29(2):25-29.［王雅琦，杨湘君，魏晓晨.化疗所致周围神经毒性的影响因素分析［J］.天津药学，2017,29(2):25-29.］
［27］ Carozzi VA，Canta A，Chiorazzi A.Chemotherapy-induced peripheral neuropathy：what do we know about mechanisms［J］?Neurosci Lett，2015，596（2）：90-107.
［28］JI WX,CHU Q.Research progress in mechanism of chemotherapy-induced neurotoxicity and its treatment ［J］.China Cancer,2012,21(5):354-357.［纪文翔，褚倩.化疗药物所致神经毒性的机制及治疗进展［J］.中国肿瘤，2012,21(5):354-357.］
［29］ F Kawakami,T Ichikawa.The role of α-synuclein and LRRK2 in Tau phosphorylation［J］.Parkinsons Disease,2015(2015):734746.
［30］ Smeyne M,Smeynen RJ.Glutathione metabolism and Parkinson's disease［J］.Free Radic Biol Med,2013(62):13-25.
备注/Memo
- 备注/Memo:
- -
